| Income Statement |
| Total Revenue | 784.80M |
|
| Revenues (USD) | 784.80M |
| Cost of Revenue | 383.83M |
| Gross Profit | 400.97M |
| Operating Expenses | 304.20M |
| Research and Development Expense | 172.43M |
| Selling, General and Administrative Expense | 90.13M |
| Operating Income | 96.77M |
| Interest Expense | 15.85M |
| Income Tax Expense | 14.72M |
| Net Income | 85.80M |
| Net Income Common Stock | 85.80M |
| Net Income Common Stock (USD) | 85.80M |
| Consolidated Income | 85.80M |
| Earnings per Basic Share | 0.97 |
| Earnings per Basic Share (USD) | 0.97 |
| Earnings per Diluted Share | 0.96 |
| Earning Before Interest & Taxes (EBIT) | 116.38M |
| Earning Before Interest & Taxes (USD) | 116.38M |
| Weighted Average Shares | 88.04M |
| Weighted Average Shares Diluted | 89.36M |
| Balance Sheet |
| Cash and Equivalents | 1.33B |
| Cash and Equivalents (USD) | 1.33B |
| Investments | 14.76M |
| Investments Non-Current | 14.76M |
| Trade and Non-Trade Receivables | 395.93M |
| Current Assets | 2.44B |
| Property, Plant & Equipment Net | 680.31M |
| Total Assets | 5.94B |
| Total Debt | 1.55B |
| Current Liabilities | 687.69M |
| Debt Non-Current | 1.55B |
| Total Liabilities | 2.47B |
| Accumulated Retained Earnings (Deficit) | 124.59M |
| Accumulated Other Comprehensive Income | 2.66M |
| Shareholders Equity | 3.47B |
| Shareholders Equity (USD) | 3.47B |
| Assets Non-Current | 3.50B |
| Total Debt (USD) | 1.55B |
| Goodwill and Intangible Assets | 2.46B |
| Inventory | 592.49M |
| Liabilities Non-Current | 1.78B |
| Trade and Non-Trade Payables | 253.23M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 50.14M |
| Net Cash Flow from Financing | -6.47M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 109.93M |
| Capital Expenditure | -24.14M |
| Issuance (Purchase) of Equity Shares | 8.73M |
| Net Cash Flow from Investing | -22.85M |
| Net Cash Flow from Operations | 139.49M |
| Effect of Exchange Rate Changes on Cash | -252.00K |
| Share Based Compensation | 34.41M |